MarketInOut Stock Screener Log In | Sign Up

Onconetix Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Onconetix Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3.35 mln
Float5.23 mln
Earnings Date11/13/2026

EPS

368
Exceptional

P / E

0.00
Anomalous

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.16
Caution advised

Relative Strength

95 / 100
Top performer

Debt / Equity

0.01
Debt-free

Business Description

Onconetix Inc. is a biotechnology company founded in 2018 and based in Cincinnati, Ohio, that develops and sells medical tools focused on men's health and cancer detection across the United States and Europe. Its main product, Proclarix, is a blood-based test used to help detect prostate cancer, offered through a partnership with LabCorp. The company also works with Immunovia AB to bring a pancreatic cancer screening test called PancreaSure to market.

Key Fundamentals

EPS368
P/E0.00
ROE-101
RPS1.09
ROIC-35.24
ROA-53.67
Interest Cover-26.28
EBITDA, mln-9.87
EV / EBITDA0.51
EV / EBIT0.51
Revenue, mln0.65

Quote Details

Last 0.561
Change -0.025 (-4.27%)
Open 0.543
Volume 1,165,648
Turnover 653,928
Average Volume 5,135,920

Financial Ratios

Pre-Tax Profit Margin-1,579
Leverage Ratio1.22
Current Ratio2.21
Price / Book0.13
Price / Tangible Book0.47
Debt / Equity0.01
Price / Sales0.02

Financial Strength

Altman Z-Score-12.97
Piotroski F-Score 4 / 9
Beneish M-Score-2.16
Short Ratio0.05
Short % of Float7.44

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 34.21% 98 / 100   
1 Month -24.61% 17 / 100   
2 Months -31.07% 19 / 100   
6 Months -91.17% 2 / 100   
1 Year -99.69% 1 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog